Erratum: Influence of lipophilicity on drug partitioning into sclera, choroid-retinal pigment epithelium, retina, trabecular meshwork, and optic nerve (Journal of Pharmacology and Experimental Therapeutics (2010) 332 (1107-1120) DOI:10.1124/jpet.109.161570);Influence of lipophilicity on drug partitioning into sclera, choroid-retinal pigment epithelium, retina, trabecular meshwork, and optic nerve

Journal of Pharmacology and Experimental Therapeutics

Volumn 332, Issue 3, 2010, Pages 1107-1120

  Kadam, Rajendra S ^a   Kompella, Uday B ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; MELANIN; METOPROLOL; NADOLOL; PINDOLOL; PROPRANOLOL; SOTALOL; TIMOLOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOROID; CILIARY BODY; CONTROLLED STUDY; CORNEA; COW; DRUG DISTRIBUTION; DRUG PROTEIN BINDING; DRUG TISSUE LEVEL; IN VITRO STUDY; IN VIVO STUDY; LENS; LIPOPHILICITY; MALE; NONHUMAN; OPTIC NERVE; PHYSICAL CHEMISTRY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RAT; RETINA; SCLERA; TISSUE DISTRIBUTION; TRABECULAR MESHWORK; VITREOUS BODY;

EID: 77249128589     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.109.161570     Document Type: Erratum

References (40)

1. Abrahamsson T, Boström S, Bräutigam J, Lagerström PO, Regårdh CG, and Vauqelin G (1988) Binding of the beta-blockers timolol and H 216/44 to ocular melanin. Exp Eye Res 47:565-577.
2. Amrite AC, Ayalasomayajula SP, Cheruvu NP, and Kompella UB (2006) Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage. Invest Ophthalmol Vis Sci 47:1149-1160.
3. Amrite AC, Edelhauser HF, and Kompella UB (2008a) Modeling of corneal and retinal pharmacokinetics after periocular drug administration. Invest Ophthalmol Vis Sci 49:320-332.
4. Amrite AC, Edelhauser HF, Singh SR, and Kompella UB (2008b) Effect of circulation on the disposition and ocular tissue distribution of 20 nm nanoparticles after periocular administration. Mol Vis 14:150-160.
5. Ayalasomayajula SP and Kompella UB (2004) Retinal delivery of celecoxib is severalfold higher following subconjunctival administration compared to systemic administration. Pharm Res 21:1797-1804.
6. Ballard P, Leahy DE, and Rowland M (2000) Prediction of in vivo tissue distribution from in vitro data 1. Experiments with markers of aqueous spaces. Pharm Res 17:660-663.
7. Busch MJ, Kobayashi K, Hoyng PF, and Mittag TW (1993) Adenylyl cyclase in human and bovine trabecular meshwork. Invest Ophthalmol Vis Sci 34:3028-3034.
8. Chen YN, Yamada H, Mao W, Matsuyama S, Aihara M, and Araie M (2007) Hypoxia-induced retinal ganglion cell death and the neuroprotective effects of betaadrenergic antagonists. Brain Res 1148:28-37.
9. Cheruvu NP, Amrite AC, and Kompella UB (2008) Effect of eye pigmentation on transscleral drug delivery. Invest Ophthalmol Vis Sci 49:333-341.
10. Cheruvu NP and Kompella UB (2006) Bovine and porcine transscleral solute transport: influence of lipophilicity and the Choroid-Bruch's layer. Invest Ophthalmol Vis Sci 47:4513-4522.
11. Durairaj C, Kim SJ, Edelhauser HF, Shah JC, and Kompella UB (2009a) Influence of dosage form on the intravitreal pharmacokinetics of diclofenac. Invest Ophthalmol Vis Sci 50:4887-4897.
12. Durairaj C, Shah JC, Senapati S, and Kompella UB (2009b) Prediction of vitreal half-life based on drug physicochemical properties: quantitative structurepharmacokinetic relationships (QSPKR). Pharm Res 26:1236-1260.
13. Fan BJ, Wang DY, Tham CC, Lam DS, and Pang CP (2008) Gene expression profiles of human trabecular meshwork cells induced by triamcinolone and dexamethasone. Invest Ophthalmol Vis Sci 49:1886-1897.
14. Floyd RA, Yoshida T, and Leigh JS Jr (1975) Changes of tissue water proton relaxation rates during early phases of chemical carcinogenesis. Proc Natl Acad Sci U S A 72:56-58.
15. Fridén M, Ducrozet F, Middleton B, Antonsson M, Bredberg U, and Hammarlund-Udenaes M (2009) Development of a high-throughput brain slice method for studying drug distribution in the central nervous system. Drug Metab Dispos 37:1226-1233.
16. Gale DC, Goulet L, Batugo M, Rewolinski D, Anderson S, Grove C, and Koudriakova T (2005) Ocular pharmacokinetics in single compound and cassette dose studies following subtenon administration in Dutch-belted rabbits. Invest Ophthalmol Vis Sci 46:5381.
17. Gargas ML, Burgess RJ, Voisard DE, Cason GH, and Andersen ME (1989) Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues. Toxicol Appl Pharmacol 98:87-99.
18. Hosoya K, Makihara A, Tsujikawa Y, Yoneyama D, Mori S, Terasaki T, Akanuma S, Tomi M, and Tachikawa M (2009) Roles of inner blood-retinal barrier organic anion transporter 3 in the vitreous/retina-to-blood efflux transport of p-aminohippuric acid, benzylpenicillin, and 6-mercaptopurine. J Pharmacol Exp Ther 329:87-93.
19. Jones R 3rd and Rhee DJ (2006) Corticosteroid-induced ocular hypertension and glaucoma: a brief review and update of the literature. Curr Opin Ophthalmol 17:163-167.
20. Kadam RS and Kompella UB (2009) Cassette analysis of eight beta-blockers in bovine eye sclera, choroid-RPE, retina, and vitreous by liquid chromatographytandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 877:253-260.
21. Kubota T, Okabe H, Hisatomi T, Yamakiri K, Sakamoto T, and Tawara A (2006) Ultrastructure of the trabecular meshwork in secondary glaucoma eyes after intravitreal triamcinolone acetonide. J Glaucoma 15:117-119.
22. Leblanc B, Jezequel S, Davies T, Hanton G, and Taradach C (1998) Binding of drugs to eye melanin is not predictive of ocular toxicity. Regul Toxicol Pharmacol 28: 124-132.
23. Majumdar S, Kansara V, and Mitra AK (2006) Vitreal pharmacokinetics of dipeptide monoester prodrugs of ganciclovir. J Ocul Pharmacol Ther 22:231-241.
24. Mannermaa E, Vellonen KS, Ryhänen T, Kokkonen K, Ranta VP, Kaarniranta K, and Urtti A (2009) Efflux protein expression in human retinal pigment epithelium cell lines. Pharm Res 26:1785-1791.
25. Maurice DM (2002) Drug delivery to the posterior segment from drops. Surv Ophthalmol 47 (Suppl 1):S41-S52.
26. Murphy JE, Janszen DB, and Gargas ML (1995) An in vitro method for determination of tissue partition coefficients of non-volatile chemicals such as 2,3,7,8-tetrachlorodibenzo-p-dioxin and estradiol. J Appl Toxicol 15:147-152.
27. Osborne NN, Wood JP, and Chidlow G (2005) Invited review: neuroprotective properties of certain beta-adrenoceptor antagonists used for the treatment of glaucoma. J Ocul Pharmacol Ther 21:175-181.
28. Ozkiriş A and Erkiliç K (2005) Complications of intravitreal injection of triamcinolone acetonide. Can J Ophthalmol 40:63-68.
29. Pitkänen L, Ranta VP, Moilanen H, and Urtti A (2005) Permeability of retinal pigment epithelium: effects of permeant molecular weight and lipophilicity. Invest Ophthalmol Vis Sci 46:641-646.
30. Poulin P and Theil FP (2000) A priori prediction of tissue:plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery. J Pharm Sci 89:16-35.
31. Proksch JW and Ward KW (2008) Cassette dosing pharmacokinetic studies for evaluation of ophthalmic drugs for posterior ocular diseases. J Pharm Sci 97: 3411-3421.
32. Raghava S, Hammond M, and Kompella UB (2004) Periocular routes for retinal drug delivery. Expert Opin Drug Deliv 1:99-114.
33. Rodgers T, Leahy D, and Rowland M (2005) Tissue distribution of basic drugs: accounting for enantiomeric, compound and regional differences amongst beta-blocking drugs in rat. J Pharm Sci 94:1237-1248.
34. Schoenwald RD and Huang HS (1983) Corneal penetration behavior of beta-blocking agents I: physiochemical factors. J Pharm Sci 72:1266-1272.
35. Smith NF, Raynaud FI, and Workman P (2007) The application of cassette dosing for pharmacokinetic screening in small-molecule cancer drug discovery. Mol Cancer Ther 6:428-440.
36. Smithen LM, Ober MD, Maranan L, and Spaide RF (2004) Intravitreal triamcinolone acetonide and intraocular pressure. Am J Ophthalmol 138:740-743.
37. Stepień KB and Wilczok T (1982) Studies of the mechanism of chloroquine binding to synthetic DOPA-melanin. Biochem Pharmacol 31:3359-3365.
38. Wiczling P, Kawczak P, Nasal A, and Kaliszan R (2006) Simultaneous determination of pKa and lipophilicity by gradient RP HPLC. Anal Chem 78:239-249.
39. Wood JP, Schmidt KG, Melena J, Chidlow G, Allmeier H, and Osborne NN (2003) The beta-adrenoceptor antagonists metipranolol and timolol are retinal neuroprotectants: comparison with betaxolol. Exp Eye Res 76:505-516.
40. Zane PA, Brindle SD, Gause DO, O'Buck AJ, Raghavan PR, and Tripp SL (1990) Physicochemical factors associated with binding and retention of compounds in ocular melanin of rats: correlations using data from whole-body autoradiography and molecular modeling for multiple linear regression analyses. Pharm Res 7:935-941.